Telisotuzumab vedotin (anti-c-Met) - Primary antibody, specific to MET, Purity>90% (SDS-PAGE&SEC), Human IgG1, INHIBITOR of Tubulin inhibitor, INHIBITOR of Tubulin inhibitor
Telisotuzumab vedotin (anti-c-Met) - Primary antibody, specific to MET, Purity>90% (SDS-PAGE&SEC), Human IgG1, INHIBITOR of Tubulin inhibitor, INHIBITOR of Tubulin inhibitor
GRADE & PURITYAnimal Free?Animal-free — produced without animal-derived components to reduce contamination risk. Use in biomanufacturing and culture avoiding animal-origin material.Carrier Free?Carrier-free — supplied without added carrier protein/stabilizer. Use when carriers (e.g. BSA) would interfere with conjugation or sensitive assays.Recombinant?Recombinant — produced via recombinant expression for defined sequence and consistency. Use for reproducible, animal-free proteins of known origin.Validated?Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated.ExactAb™?ExactAb™ — Aladdin's antibody line emphasizing precision and validated quality. Use for reliable, specificity-validated antibody applications.Low Endotoxin?Low-endotoxin grade — endotoxin reduced to low controlled levels. Use in sensitive biological work where high endotoxin would interfere.Azide Free?Azide-free — without sodium azide preservative. Use in conjugations, cell work, or assays where azide is toxic or inhibitory.≥90%(SDS-PAGE&SEC-HPLC)See COA
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥90%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
🌡
Storage & shipping
Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
📋
Quality documents
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
📚
Literature proof
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Descripción general
Telisotuzumab vedotin (anti-c-Met) is an antibody-drug conjugate (ADCs) targeting c-Met. Telisotuzumab vedotin (anti-c-Met) consists of Monomethyl Auristatin E (MMAE), Telisotuzumab antibody and a cleavable mc-val-cit-PABC type linker. Telisotuzumab vedotin (anti-c-Met) can be used in cancer research. Purity >90% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg
Specifications
Product Name
Telisotuzumab vedotin (anti-c-Met) - Primary antibody, specific to MET, Purity>90% (SDS-PAGE&SEC), Human IgG1, INHIBITOR of Tubulin inhibitor
Sinónimos
AUTS9 antibody | c met antibody | D249 antibody | Hepatocyte growth factor receptor antibody | HGF antibody | HGF receptor antibody | HGF/SF receptor antibody | HGFR antibody | MET antibody | Met proto oncogene antibody | Met proto oncogene tyrosine kinas
Especificaciones y pureza
Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥90%(SDS-PAGE&SEC-HPLC), See COA
Store at -80°C,Avoid repeated freezing and thawing
Enviado en
Dry ice packs + Cold packs
Estabilidad y almacenamiento
Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
Imágenes
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - Flow Cytometry Flow Cytometry analysis of Hela cells labelling c-Met (red) with Telisotuzumab vedotin (anti-c-Met) (Ab183336). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - Flow Cytometry Flow Cytometry analysis of A549 cells labelling c-Met (red) with Telisotuzumab vedotin (anti-c-Met) (Ab183336). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - ELISA Immobilized Human HGFR/c-MET protein (rp169642) at 1.0 μg/mL can bind Telisotuzumab vedotin (anti-c-Met) (Ab183336) with the EC50 of 298.4 ng/mL.
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - SEC The purity of Telisotuzumab vedotin (anti-c-Met) (Ab183336) is more than 95% verified by HPLC.
Documentation
📋 Safety Data Sheet (SDS)
Comprehensive hazard, handling, storage, and regulatory compliance document.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
ZJ24F0505688
